FDA.reportPublic FDA data

POLYETHYLENE GLYCOL 8000

Substance profile for UNII Q662QK8M3B, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Substance Identity#

UNII
Q662QK8M3B
Preferred term
POLYETHYLENE GLYCOL 8000
Registry number
25322-68-3
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
Polymer substance not supported

Chemical And Database Identifiers#

RxCUI
1307312
PubChem
0
NCIt
C84088
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
RxNorm1307312https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1307312
NCI ThesaurusC84088https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C84088
FDA Substance Registration SystemQ662QK8M3Bhttps://precision.fda.gov/uniisearch/srs/unii/Q662QK8M3B

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BThese highlights do not include all the information needed to use ATORVASTATIN calcium tablets safely and effectively. See full prescribing information for ATORVASTATIN calcium tablets. ATORVASTATIN calcium tablets for oral administration Initial U.S. Approval: 19961
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BMIRTAZAPINE1
Polyethylene Glycol 8000INACTIVE INGREDIENTQ662QK8M3BL-Methyl-MC Tablets3
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BAMOXICILLIN - amoxicillin tablet, film coated1
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BThese highlights do not include all the information needed to use atovaquone and proguanil hydrochloride tablets safely and effectively. See full prescribing information for atovaquone and proguanil hydrochloride tablets . ATOVAQUONE AND PROGUANIL HYDROCHLORIDE TABLETS, for oral administration Initial U.S. Approval: 20001
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BTriamterene and Hydrochlorothiazide Tablets USP Revised: April 2012 Rx only1
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BSpironolactone Tablets, USP1
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BMETFORMIN HYDROCHLORIDE tablet1
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BSpironolactone Tablets, USP2
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BVerapamil Hydrochloride Extended-Release Tablets, USP Rx Only1
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BThese highlights do not include all the information needed to use atorvastatin calcium tablets safely and effectively. See full prescribing information for atorvastatin calcium tablets. Atorvastatin Calcium Tablets for oral administration Initial U.S. Approval: 19962
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BCitalopram Tablets, USP 10 mg, 20 mg, and 40 mg Rx Only1
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BFalessa Kit5
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BThese highlights do not include all the information needed to use divalproex sodium extended-release tablets USP safely and effectively. See full prescribing information for divalproex sodium extended-release tablets USP. DIVALPROEX Sodium Extended-Release Tablets USP, for Oral Use Initial U.S. Approval: 20002
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BPENTOXIFYLLINE EXTENDED-RELEASE TABLETS, USP 400 mg1
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BThese highlights do not include all the information needed to use metoprolol succinate extended-release tablets USP safely and effectively. See full prescribing information for metoprolol succinate extended release tablets USP. Metoprolol succinate extended-release tablets USP Initial U.S. Approval: 19921
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BThese highlights do not include all the information needed to use Diovan safely and effectively. See full prescribing information for Diovan. Diovan (valsartan) Tablets Initial U.S. Approval: 19962
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BSpironolactone Tablets, USP2
polyethylene glycol 8000INACTIVE INGREDIENTQ662QK8M3BFluocinonide Cream USP, 0.05% Fluocinonide Cream USP, 0.05% (Emulsified Base) Fluocinonide Gel USP, 0.05% Fluocinonide Ointment USP, 0.05%2
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BThese highlights do not include all the information needed to use olanzapine tablets USP safely and effectively. See full prescribing information for olanzapine tablets USP. OLANZAPINE tablets USP for oral use. Initial U.S. Approval: 19962
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BNifedipine Extended-Release Tablets, USP For Oral Use Rx Only1
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BThese highlights do not include all the information needed to use quetiapine fumarate tablets safely and effectively. See full prescribing information for quetiapine fumarate tablets. QUETIAPINE fumarate tablets for oral use Initial U.S. Approval: 19972
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BPENTOXIFYLLINE EXTENDED-RELEASE TABLETS, USP 400 mg1
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BNifedipine Extended-Release Tablets, USP4
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BThese highlights do not include all the information needed to use ATORVASTATIN CALCIUM safely and effectively. See full prescribing information for ATORVASTATIN CALCIUM. ATORVASTATIN CALCIUM (ATORVASTATIN CALCIUM) TABLET, FILM COATED for ORAL use. Initial U.S. Approval: 20123
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BFluvoxamine Maleate Tablets These highlights do not include all the information needed to use Fluvoxamine Maleate Tablets safely and effectively. See full prescribing information for Fluvoxamine Maleate Tablets. Fluvoxamine Maleate Tablets for oral administration Initial U.S. Approval: 19941
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BThese highlights do not include all the information needed to use atorvastatin calcium tablets safely and effectively. See full prescribing information for atorvastatin calcium tablets. Atorvastatin Calcium Tablets for oral administration Initial U.S. Approval: 19964
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BThese highlights do not include all the information needed to use amoxicillin tablets safely and effectively. See full prescribing information for amoxicillin tablets, USP. Amoxicillin Tablets, USP Initial U.S. Approval: 1974 To reduce the development of drug-resistant bacteria and maintain the effectiveness of amoxicillin tablets, USP and other antibacterial drugs, amoxicillin tablets, USP should be used only to treat infections that are proven or strongly suspected to be caused by bacteria.1
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BMirtazapine Tablets, USP 15 mg, 30 mg and 45 mg Rx Only2
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BAtovaquone and Proguanil Hydrochloride Tablets1
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BCYCLOBENZAPRINE HYDROCHLORIDE TABLETS USP1
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BThese highlights do not include all the information needed to use atorvastatin calcium tablets safely and effectively. See full prescribing information for atorvastatin calcium tablets. Atorvastatin Calcium Tablets for oral administration Initial U.S. Approval: 19963
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BThese highlights do not include all the information needed to use atorvastatin calcium tablets safely and effectively. See full prescribing information for atorvastatin calcium tablets. Atorvastatin Calcium Tablets for oral administration Initial U.S. Approval: 19961
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Amoxicillin and Clavulanate Potassium Tablets USP, Amoxicillin and Clavulanate Potassium for Oral Suspension USP, and Amoxicillin and Clavulanate Potassium Tablets USP (Chewable) safely and effectively. See full prescribing information for Amoxicillin and Clavulanate Potassium Tablets USP, Amoxicillin and Clavulanate Potassium for Oral Suspension USP, and Amoxicillin and Clavulanate Potassium Tablets USP1
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BThese highlights do not include all the information needed to use amoxicillin tablets safely and effectively. See full prescribing information for amoxicillin tablets, USP. Amoxicillin Tablets, USP Initial U.S. Approval: 1974 To reduce the development of drug-resistant bacteria and maintain the effectiveness of amoxicillin tablets, USP and other antibacterial drugs, amoxicillin tablets, USP should be used only to treat infections that are proven or strongly suspected to be caused by bacteria.1
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BAtovaquone and Proguanil Hydrochloride Tablets1
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BThese highlights do not include all the information needed to use Lescol ® / Lescol ® XL safely and effectively. See full prescribing information for Lescol ® / Lescol ® XL. Lescol ® (fluvastatin sodium) capsules/ Lescol ® XL (fluvastatin sodium) extended-release tablets for oral use Initial U.S. Approval: 1993/ 20002
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BImipramine Hydrochloride Tablets USP1
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BThese highlights do not include all the information needed to use metoprolol succinate extended-release tablets USP safely and effectively. See full prescribing information for metoprolol succinate extended release tablets USP. Metoprolol succinate extended-release tablets USP Initial U.S. Approval: 19923
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BTriamterene and Hydrochlorothiazide Tablets USP Revised: April 2012 Rx only1
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BAMOXICILLIN AND CLAVULANATE POTASSIUM TABLETS USP, 500 mg/125 mg and 875 mg/125 mg 2274 2275 Rx only1
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BAtovaquone and Proguanil Hydrochloride Tablets1
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BFLUOCINONIDE CREAM USP, 0.05% (Emulsified Base) FLUOCINONIDE CREAM USP, 0.05% FLUOCINONIDE GEL USP, 0.05% FLUOCINONIDE OINTMENT USP, 0.05% 0262 0263 0264 0265 FOR TOPICAL/EXTERNAL USE ONLY NOT FOR OPHTHALMIC USE Rx only1
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BAMOXICILLIN AND CLAVULANATE POTASSIUM TABLETS USP, 500 mg/125 mg and 875 mg/125 mg 2274 2275 Rx only1
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BAtovaquone and Proguanil Hydrochloride Tablets1
polyethylene glycol 8000INACTIVE INGREDIENTQ662QK8M3BThese highlights do not include all the information needed to use DEXILANT safely and effectively. See full prescribing information for DEXILANT. DEXILANT (dexlansoprazole) delayed-release capsules, for oral use Initial U.S. Approval: 1995 (lansoprazole)2
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BThese highlights do not include all the information needed to use Zolpidem Tartrate Tablets, USP safely and effectively. See full prescribing information for Zolpidem Tartrate Tablets, USP. Zolpidem Tartrate Tablets, USP - CIV Initial U.S. Approval: 19927
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BATACAND HCT® 16-12.5 ( candesartan cilexetil−hydrochlorothiazide ) TABLETS ATACAND HCT® 32-12.5 ( candesartan cilexetil−hydrochlorothiazide ) TABLETS ATACAND HCT® 32–25 candesartan cilexetil-hydrochlorothiazide2
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BUnknown Title1
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BThese highlights do not include all the information needed to use Diovan safely and effectively. See full prescribing information for Diovan. Diovan (valsartan) Tablets Initial U.S. Approval: 19963
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BAMOXICILLIN AND CLAVULANATE POTASSIUM TABLETS USP, 500 mg/125 mg and 875 mg/125 mg 2274 2275 Rx only1
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3Bbe65d31a-87c1-4f37-a55d-7395bfe3642a2
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BZOMIG ® (zolmitriptan) TABLETS ZOMIG-ZMT ® (zolmitriptan) ORALLY DISINTEGRATING TABLETS2
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BThese highlights do not include all the information needed to use metoprolol succinate extended-release tablets USP safely and effectively. See full prescribing information for metoprolol succinate extended release tablets USP. Metoprolol succinate extended-release tablets USP Initial U.S. Approval: 19921
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BThese highlights do not include all the information needed to use Diovan safely and effectively. See full prescribing information for Diovan. Diovan (valsartan) Tablets Initial U.S. Approval: 19961
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BAmoxicillin Tablets, USP2
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BThese highlights do not include all the information needed to use metoprolol succinate extended-release tablets USP safely and effectively. See full prescribing information for metoprolol succinate extended release tablets USP. Metoprolol succinate extended-release tablets USP for Oral Use Initial U.S. Approval: 19923
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BThese highlights do not include all the information needed to use Calcium Acetate Capsules safely and effectively. See full prescribing information for Calcium Acetate Capsules. Calcium Acetate Capsules, 667 mg Initial U.S. Approval: 19907
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3B0d466214-78a8-44cd-923c-c286a0f74f661
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BThese highlights do not include all the information needed to use donepezil hydrochloride tablets safely and effectively. See full prescribing information for donepezil hydrochloride tablets. Donepezil hydrochloride tablets Initial U.S. Approval: 19961
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3B3e0cd209-220f-42a0-b13d-3ef13bdb6f7d4
polyethylene glycol 8000INACTIVE INGREDIENTQ662QK8M3BThese highlights do not include all the information needed to use ROZEREM safely and effectively. See full prescribing information for ROZEREM. ROZEREM (ramelteon) tablet, film coated for oral use Initial U.S. Approval: 20051
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BThese highlights do not include all the information needed to use ARICEPT safely and effectively. See full prescribing information for ARICEPT Tablets and ARICEPT Orally Disintegrating Tablets (ODT). ARICEPT ® (donepezil hydrochloride) tablets Initial U.S. Approval: 19962
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BHYDROCODONE BITARTRATE AND IBUPROFEN TABLETS 7.5 mg/200 mg1
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BFluocinonide Cream USP, 0.05% Fluocinonide Cream USP, 0.05% (Emulsified Base) Fluocinonide Gel USP, 0.05% Fluocinonide Ointment USP, 0.05%1
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3Bc095ffa5-3786-44ef-9a66-e8441e39dee11
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BNAPROXEN SODIUM TABLETS USP Rx only1
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BTriamterene and Hydrochlorothiazide Tablets USP Rx only1
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3B983ce15f-cd37-4f3a-9e51-205860e809763
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BGris-PEG ® (griseofulvin ultramicrosize) Tablets, USP 125 mg; 250 mg1
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BCalcium Acetate Capsules2
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3B6b0e60bb-0e9a-45a7-8f92-a43d939f8deb3
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BACTOPLUS MET® (pioglitazone hydrochloride and metformin hydrochloride) tablets2
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3B7a51d289-2013-4d37-adf2-91ea49df79321
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3Bc83616c9-c222-4e3e-91bd-c7839406bb2a1
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BNAPROXEN SODIUM TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3882
Polyethylene Glycol 8000INACTIVE INGREDIENTQ662QK8M3BETODOLAC TABLET, EXTENDED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3618
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BDIOVAN (VALSARTAN) TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3594
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BDIOVAN (VALSARTAN) TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3593
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BHYDROCODONE BITARTRATE AND IBUPROFEN TABLET, FILM COATED [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3325
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BDIOVAN (VALSARTAN) TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3218
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BROZEREM TABLET, FILM COATED [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3168
polyethylene glycol 8000INACTIVE INGREDIENTQ662QK8M3BNAPROXEN SODIUM TABLET [BRYANT RANCH PREPACK]1001
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BARICEPT (DONEPEZIL HYDROCHLORIDE) TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BATACAND HCT (CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE) TABLET [BRYANT RANCH PREPACK]1000
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BATORVASTATIN CALCIUM TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BATORVASTATIN CALCIUM TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BATORVASTATIN CALCIUM TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BATOVAQUONE AND PROGUANIL HCL (ATOVAQUONE AND PROGUANIL HYDROCHLORIDE) TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BDIOVAN (VALSARTAN) TABLET [BRYANT RANCH PREPACK]1000
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BDIOVAN (VALSARTAN) TABLET [BRYANT RANCH PREPACK]1000
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BETODOLAC TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK]1000
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BIMIPRAMINE HYDROCHLORIDE TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BPENTOXIFYLLINE TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK]1000
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BVALSARTAN AND HYDROCHLOROTHIAZIDE TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BCALCIUM ACETATE (CALCIUM ACETATE) CAPSULE [REMEDYREPACK INC. ]79
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BRAPAMUNE (SIROLIMUS) SOLUTION RAPAMUNE (SIROLIMUS) TABLET, SUGAR COATED [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.]47
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BFYCOMPA (PERAMPANEL) KIT FYCOMPA (PERAMPANEL) TABLET [EISAI INC.]25
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BALTOPREV (LOVASTATIN) TABLET, EXTENDED RELEASE [SHIONOGI INC.]23
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BOSMOPREP (SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, SODIUM PHOSPHATE, DIBASIC ANHYDROUS) TABLET [SALIX PHARMACEUTICALS, INC.]20
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BATACAND HCT (CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE) TABLET ATACAND HCT (CANDESARTAN CILEXETIL HYDROCHLOROTHIAZIDE) TABLET [ASTRAZENECA LP]18
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BGABAPENTIN TABLET [TEVA PHARMACEUTICALS USA INC]18
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BGILDESS 1.5/30 (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL) TABLET, FILM COATED [QUALITEST PHARMACEUTICALS]18
polyethylene glycol 8000INACTIVE INGREDIENTQ662QK8M3BNAPROSYN (NAPROXEN) TABLET EC-NAPROSYN (NAPROXEN) TABLET, DELAYED RELEASE NAPROSYN (NAPROXEN) SUSPENSION ANAPROX (NAPROXEN SODIUM) TABLET ANAPROX DS (NAPROXEN SODIUM) TABLET [GENENTECH, INC.]18
polyethylene glycol 8000INACTIVE INGREDIENTQ662QK8M3BDEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [TAKEDA PHARMACEUTICALS AMERICA, INC.]17
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BGILDESS 1/20 (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL) TABLET, FILM COATED [QUALITEST PHARMACEUTICALS]17
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BAMOXICILLIN AND CLAVULANATE POTASSIUM TABLET, FILM COATED AMOXICILLIN AND CLAVULANATE POTASSIUM POWDER, FOR SUSPENSION AMOXICILLIN AND CLAVULANATE POTASSIUM TABLET, CHEWABLE [TEVA PHARMACEUTICALS USA INC]16
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BARICEPT (DONEPEZIL HYDROCHLORIDE) TABLET, FILM COATED ARICEPT ODT (DONEPEZIL HYDROCHLORIDE) TABLET, ORALLY DISINTEGRATING [EISAI INC.]16
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BMALARONE (ATOVAQUONE AND PROGUANIL HYDROCHLORIDE) TABLET, FILM COATED [GLAXOSMITHKLINE LLC]16
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BCALCIUM ACETATE CAPSULE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]15
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BDIOVAN (VALSARTAN) TABLET [NOVARTIS PHARMACEUTICALS CORPORATION]15
polyethylene glycol 8000INACTIVE INGREDIENTQ662QK8M3BACTOPLUS MET (PIOGLITAZONE AND METFORMIN HYDROCHLORIDE) TABLET, FILM COATED [TAKEDA PHARMACEUTICALS AMERICA, INC.]14
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BCIPROFLOXACIN TABLET, FILM COATED [IVAX PHARMACEUTICALS, INC.]14
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BZOMIG (ZOLMITRIPTAN) TABLET ZOMIG ZMT (ZOLMITRIPTAN) TABLET, ORALLY DISINTEGRATING [ASTRAZENECA PHARMACEUTICALS LP]14
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BCIPROFLOXACIN TABLET, FILM COATED, EXTENDED RELEASE [WATSON PHARMA, INC.]13
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BSPIRONOLACTONE TABLET [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC]13
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BAMRIX (CYCLOBENZAPRINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [CEPHALON, INCORPORATED]12
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BATORVASTATIN CALCIUM (ATORVASTATIN CALCIUM) TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]12
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BATORVASTATIN CALCIUM TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]12
POLYETHYLENE GLYCOL 8000INACTIVE INGREDIENTQ662QK8M3BMALARONE (ATOVAQUONE AND PROGUANIL HYDROCHLORIDE) TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]12